Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.750
0.00 (0.00%)
Mar 5, 2026, 9:30 AM EST
Silence Therapeutics Employees
Silence Therapeutics had 116 employees as of December 31, 2024. The number of employees increased by 7 or 6.42% compared to the previous year.
Employees
116
Change (1Y)
7
Growth (1Y)
6.42%
Revenue / Employee
$4,819
Profits / Employee
-$763,897
Market Cap
259.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| Vaxart | 105 |
| Nuo Therapeutics | 9 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
| ZIVO Bioscience | 7 |
| Harvard Apparatus Regenerative Technology | 8 |
Silence Therapeutics News
- 1 day ago - Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 2 months ago - Silence Therapeutics Announces Leadership Changes - Business Wire
- 3 months ago - Silence Therapeutics: Divesiran Targets High-Burden PV - Seeking Alpha
- 4 months ago - Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference - Business Wire
- 4 months ago - Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 4 months ago - Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV) - Business Wire
- 6 months ago - Silence Therapeutics Plc (SLN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 months ago - Silence Therapeutics to Participate in September Investor Conferences - Business Wire